Cybin Initiates At-The-Market Equity Program of up to US$100 Million

Core Viewpoint - Cybin Inc. has launched an at-the-market equity program to issue and sell up to US$100 million of common shares to enhance its capital structure and support its innovative mental healthcare initiatives [1] Group 1: Company Overview - Cybin Inc. is a clinical-stage neuropsychiatry company focused on advancing mental healthcare through the development of next-generation treatment options [1] Group 2: Financial Strategy - The newly announced ATM Program allows Cybin to issue and sell common shares from treasury, providing the company with additional financial flexibility [1]